Connor, Clark & Lunn Investment Management »

Apogee Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $958k 13k 75.48

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Shopify Cl A Sub Vtg Shs (SHOP)
Toronto Dominion Bk Ont Com New (TD)
Cibc Cad (CM)
NVIDIA Corporation (NVDA)
Bk Nova Cad (BNS)
Apple (AAPL)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Microsoft Corporation (MSFT)
Tc Energy Corp (TRP)
Celestica (CLS)
Enbridge (ENB)
Amazon (AMZN)
Barrick Mng Corp Com Shs (B)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Rtw Investments
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Alliancebernstein
Perceptive Advisors
Affinity Asset Advisors
Citadel Advisors
Jpmorgan Chase & Co

View all funds holding Apogee Therapeutics